GoodRx(GDRX)
Search documents
GoodRx(GDRX) - 2022 Q4 - Annual Report
2023-02-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-39549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 47-5104396 (State or other jurisdiction ...
GoodRx(GDRX) - 2022 Q3 - Earnings Call Transcript
2022-11-09 01:14
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Whitney Notaro – Vice President-Investor Relations Doug Hirsch – Co-Founder and Co-Chief Executive Officer Trevor Bezdek – Co-Founder and Co-Chief Executive Officer Karsten Voermann – Chief Financial Officer Conference Call Participants Jailendra Singh – Truist Michael Cherny – Bank of America Eric Sheridan – Goldman Sachs Doug Anmuth – JPMorgan Stephanie Davis – SVB Securities Craig Hettenb ...
GoodRx(GDRX) - 2022 Q3 - Earnings Call Presentation
2022-11-08 23:08
Q3 2022 Earnings Presentation November 8, 2022 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our future operations, growth and financial results, the benefits to consumers or GoodRx of our agreements with pa ...
GoodRx(GDRX) - 2022 Q2 - Earnings Call Transcript
2022-08-08 22:48
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Whitney Notaro - Vice President-Investor Relations Doug Hirsch - Co-Founders & Co-Chief Executive Officer Trevor Bezdek - Co-Founders & Co-Chief Executive Officer Karsten Voermann - Chief Financial Officer Conference Call Participants Glen Santangelo - Jefferies Sandy Draper - Guggenheim Partners Stephanie Davis - SVB Securities Michael Cherny - BofA Craig Hettenbach - Morgan Stanley Mark Maha ...
GoodRx(GDRX) - 2022 Q1 - Earnings Call Transcript
2022-05-09 23:12
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Whitney Notaro - Vice President, Investor Relations Doug Hirsch - Co-Founder & Co-Chief Executive Officer Trevor Bezdek - Co-Founder Co-Chief Executive Officer, Karsten Voermann - Chief Financial Officer Conference Call Participants Justin Post - Bank of America John Ransom - Raymond James Mark Mahaney - Evercore George Hill - Deutsche Bank Sean Dodge - RBC Capital Markets Sandy Draper - Guggenhe ...
GoodRx Holdings (GDRX) acquisition of vitaCare - Slideshow
2022-03-07 19:24
To acquire Investor Presentation March 7, 2022 Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the benefits of the vitaCare acquisition, the expected timing of the closing of the vitaCare acquisition, if at all, the impact to ...
GoodRx(GDRX) - 2021 Q4 - Earnings Call Transcript
2022-03-01 00:28
Goodrx Holdings, Inc. (NASDAQ:GDRX) Q4 2021 Earnings Conference Call February 28, 2022 5:00 PM ET Company Participants Whitney Notaro - Vice President, Investor Relations Doug Hirsch - Founder & Co-Chief Executive Officer Trevor Bezdek - Founder Co-Chief Executive Officer, Karsten Voermann - Chief Financial Officer Conference Call Participants Jailendra Singh - Credit Suisse Eric Sheridan - Goldman Sachs Stephanie Davis - SVB Leerink John Ransom - Raymond James Ricky Goldwasser - Morgan Stanley Stephen Vali ...
GoodRx(GDRX) - 2021 Q3 - Earnings Call Presentation
2021-11-12 20:55
Q3 2021 Letter to Shareholders November 10, 2021 GoodRx helps Americans get the healthcare they need at a price they can afford. I use GoodRx myself because I have a high deductible insurance plan. Paying $100 for a medication is ridiculous even for a doctor. Alysia Ogburia, MD Primary Care Physician GoodRx Holdings, Inc. Q3 2021 Letter to Shareholders 2 Perspectives from Doug and Trevor | --- | --- | |---------------------------------------------------------------------------------------------------------- ...
GoodRx(GDRX) - 2021 Q3 - Earnings Call Transcript
2021-11-11 02:06
Goodrx Holdings, Inc. (NASDAQ:GDRX) Q3 2021 Earnings Conference Call November 10, 2021 5:00 PM ET Company Participants Whitney Notaro - VP, IR Douglas Hirsch - Co-CEO & Director Trevor Bezdek - Co-CEO, Secretary & Director Karsten Voermann - CFO Conference Call Participants Jailendra Singh - Crédit Suisse Sean Dodge - RBC Capital Markets Stephanie Davis - SVB Leerink John Ransom - Raymond James & Associates George Hill - Deutsche Bank Douglas Anmuth - JPMorgan Chase & Co. Vikram Kesavabhotla - Robert W. Bai ...
GoodRx(GDRX) - 2021 Q2 - Earnings Call Transcript
2021-08-12 22:31
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2021 Earnings Conference Call August 12, 2021 8:00 AM ET Company Participants Whitney Notaro – Vice President-Investor Relations Trevor Bezdek – Co-Founder and Co-Chief Executive Officer Doug Hirsch – Co-Founder and Co-Chief Executive Officer Bansi Nagji – President-Healthcare Karsten Voermann – Chief Financial Officer Conference Call Participants Stephanie Davis – SVB Leerink Mark Mahaney – Evercore ISI Charles Rhyee – Cowen Ross Sandler – Barclays Justin Post – Bank ...